MedTech Catapult, a national initiative spearheaded by the Agency for Science, Technology and Research (A*STAR), officially launched on 12 February 2025 at Biopolis, Singapore.
This $38m project aims to fast-track the development and commercialisation of high-value life science instruments and medical devices, addressing key challenges faced by medtech innovators in product engineering, regulatory approval, and scalable manufacturing.
The launch event was officiated by Tan See Leng, Minister for Manpower and Second Minister for Trade and Industry, who also unveiled a local supplier and contract manufacturer directory. This directory is designed to connect medtech product owners with local partners, fostering co-innovation and efficient production scaling.
MedTech Catapult’s mission is to bridge the gap between concept and market for medtech products by collaborating with clinicians, regulators, and industry experts. The initiative supports projects like Castomize’s Remouldable Orthopaedic Cast and Dornier MedTech’s Smart System for Enhanced Laser Lithotripsy, leveraging its expertise in design, development, and manufacturing optimisation.
Dr Mary Kan, Programme Director for MedTech Catapult, emphasised the importance of the new directory, stating it reflects the initiative’s commitment to supporting Singapore’s medtech ecosystem. “This directory serves as a vital tool to connect product owners with a network of partners offering specialised capabilities,” she said.
The establishment of MedTech Catapult underscores Singapore’s dedication to advancing healthcare solutions and solidifying its status as a global leader in medtech innovation.
This news story was carefully selected and published by a human editor, though the content itself was AI-generated. If you spot an error, please report it here.
